Format
Sort by
Items per page

Send to

Choose Destination

Best matches for antidepressive agents AND depressive disorder AND fetus AND pregnancy:

Antidepressants, pregnancy, and stigma: how we are failing mothers and babies. Osborne LM et al. J Nerv Ment Dis. (2015)

[Antidepressant use in pregnancy: a critical review of the risk and benefits]. Goracci A et al. Riv Psichiatr. (2015)

Antidepressant medication and pregnancy: time for randomized controlled trials. Howland RH et al. J Psychosoc Nurs Ment Health Serv. (2013)

Search results

Items: 1 to 20 of 68

1.

Antidepressant Exposure During Pregnancy and Risk of Autism in the Offspring, 1: Meta-Review of Meta-Analyses.

Andrade C.

J Clin Psychiatry. 2017 Sep/Oct;78(8):e1047-e1051. doi: 10.4088/JCP.17f11903. Review.

2.

Sertraline in pregnancy - Therapeutic drug monitoring in maternal blood, amniotic fluid and cord blood.

Paulzen M, Goecke TW, Stickeler E, GrĂ¼nder G, Schoretsanitis G.

J Affect Disord. 2017 Apr 1;212:1-6. doi: 10.1016/j.jad.2017.01.019. Epub 2017 Jan 21.

PMID:
28129551
3.

Fluoxetine normalizes the effects of prenatal maternal stress on depression- and anxiety-like behaviors in mouse dams and male offspring.

Salari AA, Fatehi-Gharehlar L, Motayagheni N, Homberg JR.

Behav Brain Res. 2016 Sep 15;311:354-367. doi: 10.1016/j.bbr.2016.05.062. Epub 2016 Jun 1.

PMID:
27263073
4.

Safety of Selective Serotonin Reuptake Inhibitors in Pregnancy: A Review of Current Evidence.

Alwan S, Friedman JM, Chambers C.

CNS Drugs. 2016 Jun;30(6):499-515. doi: 10.1007/s40263-016-0338-3. Review.

PMID:
27138915
5.

[Antidepressant use in pregnancy: a critical review of the risk and benefits].

Goracci A, Valdagno M, Maltinti E, Sillari S, Fagiolini A.

Riv Psichiatr. 2015 May-Jun;50(3):118-26. doi: 10.1708/1910.20792. Review. Italian.

PMID:
26156817
6.

Managing antidepressant treatment in pregnancy and puerperium. Careful with that axe, Eugene.

Gentile S.

Expert Opin Drug Saf. 2015 Jul;14(7):1011-4. doi: 10.1517/14740338.2015.1037273. Epub 2015 Apr 16.

PMID:
25882518
7.

[Are antidepressants a risk for the fetus?].

Nissen C.

MMW Fortschr Med. 2015 Jan 19;157(1):30. German. No abstract available.

PMID:
25767866
8.

Antidepressants, pregnancy, and stigma: how we are failing mothers and babies.

Osborne LM, Payne J.

J Nerv Ment Dis. 2015 Mar;203(3):164-6. doi: 10.1097/NMD.0000000000000257.

PMID:
25714253
9.

Controversies about the use of antidepressants in pregnancy.

Robinson GE.

J Nerv Ment Dis. 2015 Mar;203(3):159-63. doi: 10.1097/NMD.0000000000000256. Review.

PMID:
25714252
10.

Acute and long-term behavioral outcome of infants and children exposed in utero to either maternal depression or antidepressants: a review of the literature.

Suri R, Lin AS, Cohen LS, Altshuler LL.

J Clin Psychiatry. 2014 Oct;75(10):e1142-52. doi: 10.4088/JCP.13r08926. Review.

PMID:
25373125
11.

Prenatal SSRI exposure: Effects on later child development.

Hermansen TK, Melinder A.

Child Neuropsychol. 2015;21(5):543-69. doi: 10.1080/09297049.2014.942727. Epub 2014 Aug 4.

PMID:
25089614
12.

Warning of risk to foetus for mothers using SSRIs.

Kouros N.

Monash Bioeth Rev. 2013 Sep;31(2):22-3. No abstract available.

PMID:
24844071
13.

Returning to tricyclic antidepressants for depression during childbearing: clinical and dosing challenges.

Osborne LM, Birndorf CA, Szkodny LE, Wisner KL.

Arch Womens Ment Health. 2014 Jun;17(3):239-46. doi: 10.1007/s00737-014-0421-z. Epub 2014 Mar 26.

14.

[The safety profile of escitalopram in pregnancy and breastfeeding].

Bellantuono C, Orsolini L, Bozzi F.

Riv Psichiatr. 2013 Nov-Dec;48(6):407-14. doi: 10.1708/1379.15335. Review. Italian.

PMID:
24441517
15.

Duloxetine and pregnancy outcomes: safety surveillance findings.

Hoog SL, Cheng Y, Elpers J, Dowsett SA.

Int J Med Sci. 2013;10(4):413-9. doi: 10.7150/ijms.5213. Epub 2013 Feb 28.

16.

Antidepressant medication and pregnancy: time for randomized controlled trials.

Howland RH.

J Psychosoc Nurs Ment Health Serv. 2013 Feb;51(2):11-4. doi: 10.3928/02793695-20130109-01. Epub 2013 Jan 18. Review.

PMID:
23330797
17.

Maternal use of SSRIs, SNRIs and NaSSAs: practical recommendations during pregnancy and lactation.

Sie SD, Wennink JM, van Driel JJ, te Winkel AG, Boer K, Casteelen G, van Weissenbruch MM.

Arch Dis Child Fetal Neonatal Ed. 2012 Nov;97(6):F472-6. doi: 10.1136/archdischild-2011-214239. Review. Erratum in: Arch Dis Child Fetal Neonatal Ed. 2013 Mar;98(2):F180.

PMID:
23080479
18.

Fetal serotonin reuptake inhibitor antidepressant exposure: maternal and fetal factors.

Shea AK, Oberlander TF, Rurak D.

Can J Psychiatry. 2012 Sep;57(9):523-9. Review.

PMID:
23073029
19.

Early morbidity and mortality following in utero exposure to selective serotonin reuptake inhibitors: a population-based study in Western Australia.

Colvin L, Slack-Smith L, Stanley FJ, Bower C.

CNS Drugs. 2012 Jul 1;26(7):e1-14. doi: 10.2165/11634190-000000000-00000.

20.

DNA methylation in neonates born to women receiving psychiatric care.

Schroeder JW, Smith AK, Brennan PA, Conneely KN, Kilaru V, Knight BT, Newport DJ, Cubells JF, Stowe ZN.

Epigenetics. 2012 Apr;7(4):409-14. doi: 10.4161/epi.19551. Epub 2012 Apr 1.

Supplemental Content

Loading ...
Support Center